0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hemostats Market Insights and Forecast to 2028
Published Date: January 2022
|
Report Code: QYRE-Auto-10E596
Home | Market Reports | Health| Medical Devices & Equipment
Global Hemostats Market Insights and Forecast to 2028
BUY CHAPTERS

Global Hemostats Market Insights and Forecast to 2028

Code: QYRE-Auto-10E596
Report
January 2022
Pages:118
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Hemostats Market 2028

The global Hemostats market size is estimated to be worth US$ 2921.3 million in 2022 and is forecast to a readjusted size of US$ 4120.4 million by 2028 with a CAGR of 5.9% during the review period. The increasing prevalence of chronic diseases, the effectiveness of thrombin-based hemostats, and technological improvements will all contribute to the market's expansion.

Hemostats Market

Hemostats Market Trends

The primary factor in both military and civilian fatalities is hemorrhage. Over 30% of traumatic deaths in emergency settings are caused by uncontrolled hemorrhage, and severe bleeding is the primary cause of military casualties. In high-stress situations, hemostatic drugs have been shown to be useful in hospitals and can save lives. The market for hemostats will expand as a result. The medications stop mortality brought on by infections, multiple organ failure, acidosis, and hypothermia. It is a crucial stage in the recovery from trauma.

The number of surgical procedures is increasing as chronic diseases like cancer and cardiovascular problems become more common. The world's healthcare infrastructure is growing to keep up with the surge in demand for surgical procedures. The widespread usage of the items in difficult bleeding prevention during operations to protect the patient from injury drives the hemostats industry.

The use of thrombin-based hemostatic agents prior to wound closure decreased postoperative blood loss and the need for transfusions, according to studies and research analysis. Deep vein thrombosis, infection, or the incidence of additional problems are not hazards. It is the main substance utilized in knee arthroplasty procedures. The agent is easily storable at room temperature. Such advantageous qualities will increase demand for the world hemostats market. The addition of a porcine gelatin sponge, which makes it easier to apply direct pressure, can boost a thrombin hemostat's effectiveness even further.

Organ failure and significant blood loss are risks associated with invasive medical procedures and operations. Polysaccharide hemostatic devices are used to moderate blood flow effectively, which is fueling the expansion of the global hemostats market. By utilizing non-anatomical and sensitive structures, blood loss is prevented. The usage of these systems is especially advantageous for patients with arthritic illnesses, high bone density, and hemostatic problems.

Hemostats Market Share Analysis

Based on product type, with a 40% market share, thrombin-based hemostats will experience rapid expansion.

Based on application, The market share for hemostats will be dominated by hospitals due to the increase in surgical procedures and the prevalence of chronic illnesses.

Based on region, With a 35% market share, North America will have the fastest growth. This is caused by the rising elderly population, the rising number of procedures, and the significant presence of major players. On the other hand, with a combined share of 35%, Europe and China are the second-largest economies.

Segment by Type

  • Thrombin-Based Hemostats
  • Oxidized Regenerated Cellulose Based Hemostats
  • Combination Hemostats
  • Gelatin Based Hemostats
  • Collagen Based Hemostats

Segment by Application

  • Prehospital Treatment
  • Hospital Treatment

BY COMPANY

  • Ethicon
  • Pfizer
  • Baxter International Inc.
  • C. R. Bard
  • The Medicines Company
  • Anika Therapeutics
  • Advanced Medical Solutions
  • Integra LifeSciences Corporation
  • B Braun Melsungen AG
  • Gelita Medical GmbH
  • Equimedical
  • Vascular Solutions
  • Marine Polymer Technologies
  • Z-Medica, LLC
  • CryoLife
  • BioCer Entwicklungs-GmbH.
  • Biom'Up SAS

BY REGION

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • China Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE

Hemostats Market Scope

Report Metric

Details

Report Name

Hemostats Market

The market size in 2022

USD 2921.3 Million

The revenue forecast in 2028

USD 4120.4 Million

Growth Rate

Compound Annual Growth Rate (CAGR) of 5.9% from 2022 to 2028

Market size available for years

2022-2028

Forecast units

Value (USD)

Segments covered

By Type, Application, and Region

Report coverage

Revenue & volume forecast, company share, competitive landscape, growth factors, and trends

Geographic regions covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Frequently Asked Questions About This Report

1. How Big is the Hemostats Market?

Ans.  The global Hemostats market size is estimated to be worth US$ 2921.3 million in 2022 and is forecast to a readjusted size of US$ 4120.4 million by 2028.

2. What is the Hemostats Market Growth?

Ans. The global Hemostats market size is expected to grow at a compound annual growth rate of 5.9% from 2022 to 2028.

3. Who are the major key players of the Hemostats Market?

Ans. The global major manufacturers are Integra LifeSciences Corporation, B Braun Melsungen AG, Gelita Medical GmbH, Equimedical, Vascular Solutions, Marine Polymer Technologies, Z-Medica, LLC, CryoLife, BioCer Entwicklungs-GmbH., Biom'Up SAS, others.

1 Study Coverage
1.1 Hemostats Product Introduction
1.2 Market by Type
1.2.1 Global Hemostats Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Thrombin-Based Hemostats
1.2.3 Oxidized Regenerated Cellulose Based Hemostats
1.2.4 Combination Hemostats
1.2.5 Gelatin Based Hemostats
1.2.6 Collagen Based Hemostats
1.3 Market by Application
1.3.1 Global Hemostats Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Prehospital Treatment
1.3.3 Hospital Treatment
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Hemostats Sales Estimates and Forecasts 2017-2028
2.2 Global Hemostats Revenue Estimates and Forecasts 2017-2028
2.3 Global Hemostats Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Hemostats Sales by Region
2.4.1 Global Hemostats Sales by Region (2017-2022)
2.4.2 Global Sales Hemostats by Region (2023-2028)
2.5 Global Hemostats Revenue by Region
2.5.1 Global Hemostats Revenue by Region (2017-2022)
2.5.2 Global Hemostats Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Hemostats Sales by Manufacturers
3.1.1 Global Top Hemostats Manufacturers by Sales (2017-2022)
3.1.2 Global Hemostats Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hemostats in 2021
3.2 Global Hemostats Revenue by Manufacturers
3.2.1 Global Hemostats Revenue by Manufacturers (2017-2022)
3.2.2 Global Hemostats Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Hemostats Revenue in 2021
3.3 Global Hemostats Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Hemostats Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Hemostats Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Hemostats Sales by Type
4.1.1 Global Hemostats Historical Sales by Type (2017-2022)
4.1.2 Global Hemostats Forecasted Sales by Type (2023-2028)
4.1.3 Global Hemostats Sales Market Share by Type (2017-2028)
4.2 Global Hemostats Revenue by Type
4.2.1 Global Hemostats Historical Revenue by Type (2017-2022)
4.2.2 Global Hemostats Forecasted Revenue by Type (2023-2028)
4.2.3 Global Hemostats Revenue Market Share by Type (2017-2028)
4.3 Global Hemostats Price by Type
4.3.1 Global Hemostats Price by Type (2017-2022)
4.3.2 Global Hemostats Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Hemostats Sales by Application
5.1.1 Global Hemostats Historical Sales by Application (2017-2022)
5.1.2 Global Hemostats Forecasted Sales by Application (2023-2028)
5.1.3 Global Hemostats Sales Market Share by Application (2017-2028)
5.2 Global Hemostats Revenue by Application
5.2.1 Global Hemostats Historical Revenue by Application (2017-2022)
5.2.2 Global Hemostats Forecasted Revenue by Application (2023-2028)
5.2.3 Global Hemostats Revenue Market Share by Application (2017-2028)
5.3 Global Hemostats Price by Application
5.3.1 Global Hemostats Price by Application (2017-2022)
5.3.2 Global Hemostats Price Forecast by Application (2023-2028)
6 North America
6.1 North America Hemostats Market Size by Type
6.1.1 North America Hemostats Sales by Type (2017-2028)
6.1.2 North America Hemostats Revenue by Type (2017-2028)
6.2 North America Hemostats Market Size by Application
6.2.1 North America Hemostats Sales by Application (2017-2028)
6.2.2 North America Hemostats Revenue by Application (2017-2028)
6.3 North America Hemostats Market Size by Country
6.3.1 North America Hemostats Sales by Country (2017-2028)
6.3.2 North America Hemostats Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Hemostats Market Size by Type
7.1.1 Europe Hemostats Sales by Type (2017-2028)
7.1.2 Europe Hemostats Revenue by Type (2017-2028)
7.2 Europe Hemostats Market Size by Application
7.2.1 Europe Hemostats Sales by Application (2017-2028)
7.2.2 Europe Hemostats Revenue by Application (2017-2028)
7.3 Europe Hemostats Market Size by Country
7.3.1 Europe Hemostats Sales by Country (2017-2028)
7.3.2 Europe Hemostats Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Hemostats Market Size by Type
8.1.1 Asia Pacific Hemostats Sales by Type (2017-2028)
8.1.2 Asia Pacific Hemostats Revenue by Type (2017-2028)
8.2 Asia Pacific Hemostats Market Size by Application
8.2.1 Asia Pacific Hemostats Sales by Application (2017-2028)
8.2.2 Asia Pacific Hemostats Revenue by Application (2017-2028)
8.3 Asia Pacific Hemostats Market Size by Region
8.3.1 Asia Pacific Hemostats Sales by Region (2017-2028)
8.3.2 Asia Pacific Hemostats Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Hemostats Market Size by Type
9.1.1 Latin America Hemostats Sales by Type (2017-2028)
9.1.2 Latin America Hemostats Revenue by Type (2017-2028)
9.2 Latin America Hemostats Market Size by Application
9.2.1 Latin America Hemostats Sales by Application (2017-2028)
9.2.2 Latin America Hemostats Revenue by Application (2017-2028)
9.3 Latin America Hemostats Market Size by Country
9.3.1 Latin America Hemostats Sales by Country (2017-2028)
9.3.2 Latin America Hemostats Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Hemostats Market Size by Type
10.1.1 Middle East and Africa Hemostats Sales by Type (2017-2028)
10.1.2 Middle East and Africa Hemostats Revenue by Type (2017-2028)
10.2 Middle East and Africa Hemostats Market Size by Application
10.2.1 Middle East and Africa Hemostats Sales by Application (2017-2028)
10.2.2 Middle East and Africa Hemostats Revenue by Application (2017-2028)
10.3 Middle East and Africa Hemostats Market Size by Country
10.3.1 Middle East and Africa Hemostats Sales by Country (2017-2028)
10.3.2 Middle East and Africa Hemostats Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Ethicon
11.1.1 Ethicon Corporation Information
11.1.2 Ethicon Overview
11.1.3 Ethicon Hemostats Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Ethicon Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Ethicon Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Hemostats Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Baxter International Inc.
11.3.1 Baxter International Inc. Corporation Information
11.3.2 Baxter International Inc. Overview
11.3.3 Baxter International Inc. Hemostats Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Baxter International Inc. Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Baxter International Inc. Recent Developments
11.4 C. R. Bard
11.4.1 C. R. Bard Corporation Information
11.4.2 C. R. Bard Overview
11.4.3 C. R. Bard Hemostats Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 C. R. Bard Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 C. R. Bard Recent Developments
11.5 The Medicines Company
11.5.1 The Medicines Company Corporation Information
11.5.2 The Medicines Company Overview
11.5.3 The Medicines Company Hemostats Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 The Medicines Company Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 The Medicines Company Recent Developments
11.6 Anika Therapeutics
11.6.1 Anika Therapeutics Corporation Information
11.6.2 Anika Therapeutics Overview
11.6.3 Anika Therapeutics Hemostats Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Anika Therapeutics Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Anika Therapeutics Recent Developments
11.7 Advanced Medical Solutions
11.7.1 Advanced Medical Solutions Corporation Information
11.7.2 Advanced Medical Solutions Overview
11.7.3 Advanced Medical Solutions Hemostats Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Advanced Medical Solutions Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Advanced Medical Solutions Recent Developments
11.8 Integra LifeSciences Corporation
11.8.1 Integra LifeSciences Corporation Corporation Information
11.8.2 Integra LifeSciences Corporation Overview
11.8.3 Integra LifeSciences Corporation Hemostats Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Integra LifeSciences Corporation Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Integra LifeSciences Corporation Recent Developments
11.9 B Braun Melsungen AG
11.9.1 B Braun Melsungen AG Corporation Information
11.9.2 B Braun Melsungen AG Overview
11.9.3 B Braun Melsungen AG Hemostats Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 B Braun Melsungen AG Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 B Braun Melsungen AG Recent Developments
11.10 Gelita Medical GmbH
11.10.1 Gelita Medical GmbH Corporation Information
11.10.2 Gelita Medical GmbH Overview
11.10.3 Gelita Medical GmbH Hemostats Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Gelita Medical GmbH Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Gelita Medical GmbH Recent Developments
11.11 Equimedical
11.11.1 Equimedical Corporation Information
11.11.2 Equimedical Overview
11.11.3 Equimedical Hemostats Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Equimedical Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Equimedical Recent Developments
11.12 Vascular Solutions
11.12.1 Vascular Solutions Corporation Information
11.12.2 Vascular Solutions Overview
11.12.3 Vascular Solutions Hemostats Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Vascular Solutions Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Vascular Solutions Recent Developments
11.13 Marine Polymer Technologies
11.13.1 Marine Polymer Technologies Corporation Information
11.13.2 Marine Polymer Technologies Overview
11.13.3 Marine Polymer Technologies Hemostats Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Marine Polymer Technologies Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Marine Polymer Technologies Recent Developments
11.14 Z-Medica, LLC
11.14.1 Z-Medica, LLC Corporation Information
11.14.2 Z-Medica, LLC Overview
11.14.3 Z-Medica, LLC Hemostats Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Z-Medica, LLC Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Z-Medica, LLC Recent Developments
11.15 CryoLife
11.15.1 CryoLife Corporation Information
11.15.2 CryoLife Overview
11.15.3 CryoLife Hemostats Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 CryoLife Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 CryoLife Recent Developments
11.16 BioCer Entwicklungs-GmbH.
11.16.1 BioCer Entwicklungs-GmbH. Corporation Information
11.16.2 BioCer Entwicklungs-GmbH. Overview
11.16.3 BioCer Entwicklungs-GmbH. Hemostats Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 BioCer Entwicklungs-GmbH. Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 BioCer Entwicklungs-GmbH. Recent Developments
11.17 Biom'Up SAS
11.17.1 Biom'Up SAS Corporation Information
11.17.2 Biom'Up SAS Overview
11.17.3 Biom'Up SAS Hemostats Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Biom'Up SAS Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Biom'Up SAS Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Hemostats Industry Chain Analysis
12.2 Hemostats Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Hemostats Production Mode & Process
12.4 Hemostats Sales and Marketing
12.4.1 Hemostats Sales Channels
12.4.2 Hemostats Distributors
12.5 Hemostats Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Hemostats Industry Trends
13.2 Hemostats Market Drivers
13.3 Hemostats Market Challenges
13.4 Hemostats Market Restraints
14 Key Findings in The Global Hemostats Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Hemostats Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Thrombin-Based Hemostats
    Table 3. Major Manufacturers of Oxidized Regenerated Cellulose Based Hemostats
    Table 4. Major Manufacturers of Combination Hemostats
    Table 5. Major Manufacturers of Gelatin Based Hemostats
    Table 6. Major Manufacturers of Collagen Based Hemostats
    Table 7. Global Hemostats Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Hemostats Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Hemostats Sales by Region (2017-2022) & (K Pcs)
    Table 10. Global Hemostats Sales Market Share by Region (2017-2022)
    Table 11. Global Hemostats Sales by Region (2023-2028) & (K Pcs)
    Table 12. Global Hemostats Sales Market Share by Region (2023-2028)
    Table 13. Global Hemostats Revenue by Region (2017-2022) & (US$ Million)
    Table 14. Global Hemostats Revenue Market Share by Region (2017-2022)
    Table 15. Global Hemostats Revenue by Region (2023-2028) & (US$ Million)
    Table 16. Global Hemostats Revenue Market Share by Region (2023-2028)
    Table 17. Global Hemostats Sales by Manufacturers (2017-2022) & (K Pcs)
    Table 18. Global Hemostats Sales Share by Manufacturers (2017-2022)
    Table 19. Global Hemostats Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 20. Global Hemostats Revenue Share by Manufacturers (2017-2022)
    Table 21. Hemostats Price by Manufacturers (2017-2022) &(USD/Pcs)
    Table 22. Global Hemostats Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Hemostats by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemostats as of 2021)
    Table 24. Hemostats Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers Hemostats Product Offered
    Table 26. Date of Manufacturers Enter into Hemostats Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Hemostats Sales by Type (2017-2022) & (K Pcs)
    Table 29. Global Hemostats Sales by Type (2023-2028) & (K Pcs)
    Table 30. Global Hemostats Sales Share by Type (2017-2022)
    Table 31. Global Hemostats Sales Share by Type (2023-2028)
    Table 32. Global Hemostats Revenue by Type (2017-2022) & (US$ Million)
    Table 33. Global Hemostats Revenue by Type (2023-2028) & (US$ Million)
    Table 34. Global Hemostats Revenue Share by Type (2017-2022)
    Table 35. Global Hemostats Revenue Share by Type (2023-2028)
    Table 36. Hemostats Price by Type (2017-2022) & (USD/Pcs)
    Table 37. Global Hemostats Price Forecast by Type (2023-2028) & (USD/Pcs)
    Table 38. Global Hemostats Sales by Application (2017-2022) & (K Pcs)
    Table 39. Global Hemostats Sales by Application (2023-2028) & (K Pcs)
    Table 40. Global Hemostats Sales Share by Application (2017-2022)
    Table 41. Global Hemostats Sales Share by Application (2023-2028)
    Table 42. Global Hemostats Revenue by Application (2017-2022) & (US$ Million)
    Table 43. Global Hemostats Revenue by Application (2023-2028) & (US$ Million)
    Table 44. Global Hemostats Revenue Share by Application (2017-2022)
    Table 45. Global Hemostats Revenue Share by Application (2023-2028)
    Table 46. Hemostats Price by Application (2017-2022) & (USD/Pcs)
    Table 47. Global Hemostats Price Forecast by Application (2023-2028) & (USD/Pcs)
    Table 48. North America Hemostats Sales by Type (2017-2022) & (K Pcs)
    Table 49. North America Hemostats Sales by Type (2023-2028) & (K Pcs)
    Table 50. North America Hemostats Revenue by Type (2017-2022) & (US$ Million)
    Table 51. North America Hemostats Revenue by Type (2023-2028) & (US$ Million)
    Table 52. North America Hemostats Sales by Application (2017-2022) & (K Pcs)
    Table 53. North America Hemostats Sales by Application (2023-2028) & (K Pcs)
    Table 54. North America Hemostats Revenue by Application (2017-2022) & (US$ Million)
    Table 55. North America Hemostats Revenue by Application (2023-2028) & (US$ Million)
    Table 56. North America Hemostats Sales by Country (2017-2022) & (K Pcs)
    Table 57. North America Hemostats Sales by Country (2023-2028) & (K Pcs)
    Table 58. North America Hemostats Revenue by Country (2017-2022) & (US$ Million)
    Table 59. North America Hemostats Revenue by Country (2023-2028) & (US$ Million)
    Table 60. Europe Hemostats Sales by Type (2017-2022) & (K Pcs)
    Table 61. Europe Hemostats Sales by Type (2023-2028) & (K Pcs)
    Table 62. Europe Hemostats Revenue by Type (2017-2022) & (US$ Million)
    Table 63. Europe Hemostats Revenue by Type (2023-2028) & (US$ Million)
    Table 64. Europe Hemostats Sales by Application (2017-2022) & (K Pcs)
    Table 65. Europe Hemostats Sales by Application (2023-2028) & (K Pcs)
    Table 66. Europe Hemostats Revenue by Application (2017-2022) & (US$ Million)
    Table 67. Europe Hemostats Revenue by Application (2023-2028) & (US$ Million)
    Table 68. Europe Hemostats Sales by Country (2017-2022) & (K Pcs)
    Table 69. Europe Hemostats Sales by Country (2023-2028) & (K Pcs)
    Table 70. Europe Hemostats Revenue by Country (2017-2022) & (US$ Million)
    Table 71. Europe Hemostats Revenue by Country (2023-2028) & (US$ Million)
    Table 72. Asia Pacific Hemostats Sales by Type (2017-2022) & (K Pcs)
    Table 73. Asia Pacific Hemostats Sales by Type (2023-2028) & (K Pcs)
    Table 74. Asia Pacific Hemostats Revenue by Type (2017-2022) & (US$ Million)
    Table 75. Asia Pacific Hemostats Revenue by Type (2023-2028) & (US$ Million)
    Table 76. Asia Pacific Hemostats Sales by Application (2017-2022) & (K Pcs)
    Table 77. Asia Pacific Hemostats Sales by Application (2023-2028) & (K Pcs)
    Table 78. Asia Pacific Hemostats Revenue by Application (2017-2022) & (US$ Million)
    Table 79. Asia Pacific Hemostats Revenue by Application (2023-2028) & (US$ Million)
    Table 80. Asia Pacific Hemostats Sales by Region (2017-2022) & (K Pcs)
    Table 81. Asia Pacific Hemostats Sales by Region (2023-2028) & (K Pcs)
    Table 82. Asia Pacific Hemostats Revenue by Region (2017-2022) & (US$ Million)
    Table 83. Asia Pacific Hemostats Revenue by Region (2023-2028) & (US$ Million)
    Table 84. Latin America Hemostats Sales by Type (2017-2022) & (K Pcs)
    Table 85. Latin America Hemostats Sales by Type (2023-2028) & (K Pcs)
    Table 86. Latin America Hemostats Revenue by Type (2017-2022) & (US$ Million)
    Table 87. Latin America Hemostats Revenue by Type (2023-2028) & (US$ Million)
    Table 88. Latin America Hemostats Sales by Application (2017-2022) & (K Pcs)
    Table 89. Latin America Hemostats Sales by Application (2023-2028) & (K Pcs)
    Table 90. Latin America Hemostats Revenue by Application (2017-2022) & (US$ Million)
    Table 91. Latin America Hemostats Revenue by Application (2023-2028) & (US$ Million)
    Table 92. Latin America Hemostats Sales by Country (2017-2022) & (K Pcs)
    Table 93. Latin America Hemostats Sales by Country (2023-2028) & (K Pcs)
    Table 94. Latin America Hemostats Revenue by Country (2017-2022) & (US$ Million)
    Table 95. Latin America Hemostats Revenue by Country (2023-2028) & (US$ Million)
    Table 96. Middle East and Africa Hemostats Sales by Type (2017-2022) & (K Pcs)
    Table 97. Middle East and Africa Hemostats Sales by Type (2023-2028) & (K Pcs)
    Table 98. Middle East and Africa Hemostats Revenue by Type (2017-2022) & (US$ Million)
    Table 99. Middle East and Africa Hemostats Revenue by Type (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa Hemostats Sales by Application (2017-2022) & (K Pcs)
    Table 101. Middle East and Africa Hemostats Sales by Application (2023-2028) & (K Pcs)
    Table 102. Middle East and Africa Hemostats Revenue by Application (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa Hemostats Revenue by Application (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa Hemostats Sales by Country (2017-2022) & (K Pcs)
    Table 105. Middle East and Africa Hemostats Sales by Country (2023-2028) & (K Pcs)
    Table 106. Middle East and Africa Hemostats Revenue by Country (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa Hemostats Revenue by Country (2023-2028) & (US$ Million)
    Table 108. Ethicon Corporation Information
    Table 109. Ethicon Description and Major Businesses
    Table 110. Ethicon Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 111. Ethicon Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Ethicon Recent Developments
    Table 113. Pfizer Corporation Information
    Table 114. Pfizer Description and Major Businesses
    Table 115. Pfizer Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 116. Pfizer Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Pfizer Recent Developments
    Table 118. Baxter International Inc. Corporation Information
    Table 119. Baxter International Inc. Description and Major Businesses
    Table 120. Baxter International Inc. Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 121. Baxter International Inc. Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Baxter International Inc. Recent Developments
    Table 123. C. R. Bard Corporation Information
    Table 124. C. R. Bard Description and Major Businesses
    Table 125. C. R. Bard Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 126. C. R. Bard Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. C. R. Bard Recent Developments
    Table 128. The Medicines Company Corporation Information
    Table 129. The Medicines Company Description and Major Businesses
    Table 130. The Medicines Company Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 131. The Medicines Company Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. The Medicines Company Recent Developments
    Table 133. Anika Therapeutics Corporation Information
    Table 134. Anika Therapeutics Description and Major Businesses
    Table 135. Anika Therapeutics Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 136. Anika Therapeutics Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Anika Therapeutics Recent Developments
    Table 138. Advanced Medical Solutions Corporation Information
    Table 139. Advanced Medical Solutions Description and Major Businesses
    Table 140. Advanced Medical Solutions Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 141. Advanced Medical Solutions Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Advanced Medical Solutions Recent Developments
    Table 143. Integra LifeSciences Corporation Corporation Information
    Table 144. Integra LifeSciences Corporation Description and Major Businesses
    Table 145. Integra LifeSciences Corporation Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 146. Integra LifeSciences Corporation Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. Integra LifeSciences Corporation Recent Developments
    Table 148. B Braun Melsungen AG Corporation Information
    Table 149. B Braun Melsungen AG Description and Major Businesses
    Table 150. B Braun Melsungen AG Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 151. B Braun Melsungen AG Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. B Braun Melsungen AG Recent Developments
    Table 153. Gelita Medical GmbH Corporation Information
    Table 154. Gelita Medical GmbH Description and Major Businesses
    Table 155. Gelita Medical GmbH Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 156. Gelita Medical GmbH Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. Gelita Medical GmbH Recent Developments
    Table 158. Equimedical Corporation Information
    Table 159. Equimedical Description and Major Businesses
    Table 160. Equimedical Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 161. Equimedical Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
    Table 162. Equimedical Recent Developments
    Table 163. Vascular Solutions Corporation Information
    Table 164. Vascular Solutions Description and Major Businesses
    Table 165. Vascular Solutions Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 166. Vascular Solutions Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
    Table 167. Vascular Solutions Recent Developments
    Table 168. Marine Polymer Technologies Corporation Information
    Table 169. Marine Polymer Technologies Description and Major Businesses
    Table 170. Marine Polymer Technologies Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 171. Marine Polymer Technologies Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
    Table 172. Marine Polymer Technologies Recent Developments
    Table 173. Z-Medica, LLC Corporation Information
    Table 174. Z-Medica, LLC Description and Major Businesses
    Table 175. Z-Medica, LLC Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 176. Z-Medica, LLC Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
    Table 177. Z-Medica, LLC Recent Developments
    Table 178. CryoLife Corporation Information
    Table 179. CryoLife Description and Major Businesses
    Table 180. CryoLife Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 181. CryoLife Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
    Table 182. CryoLife Recent Developments
    Table 183. BioCer Entwicklungs-GmbH. Corporation Information
    Table 184. BioCer Entwicklungs-GmbH. Description and Major Businesses
    Table 185. BioCer Entwicklungs-GmbH. Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 186. BioCer Entwicklungs-GmbH. Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
    Table 187. BioCer Entwicklungs-GmbH. Recent Developments
    Table 188. Biom'Up SAS Corporation Information
    Table 189. Biom'Up SAS Description and Major Businesses
    Table 190. Biom'Up SAS Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 191. Biom'Up SAS Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
    Table 192. Biom'Up SAS Recent Developments
    Table 193. Key Raw Materials Lists
    Table 194. Raw Materials Key Suppliers Lists
    Table 195. Hemostats Distributors List
    Table 196. Hemostats Customers List
    Table 197. Hemostats Market Trends
    Table 198. Hemostats Market Drivers
    Table 199. Hemostats Market Challenges
    Table 200. Hemostats Market Restraints
    Table 201. Research Programs/Design for This Report
    Table 202. Key Data Information from Secondary Sources
    Table 203. Key Data Information from Primary Sources
List of Figures
    Figure 1. Hemostats Product Picture
    Figure 3. Global Hemostats Market Share by Type in 2021 & 2028
    Figure 3. Thrombin-Based Hemostats Product Picture
    Figure 4. Oxidized Regenerated Cellulose Based Hemostats Product Picture
    Figure 5. Combination Hemostats Product Picture
    Figure 6. Gelatin Based Hemostats Product Picture
    Figure 7. Collagen Based Hemostats Product Picture
    Figure 8. Global Hemostats Market Share by Application in 2021 & 2028
    Figure 9. Prehospital Treatment
    Figure 10. Hospital Treatment
    Figure 11. Hemostats Report Years Considered
    Figure 12. Global Hemostats Sales 2017-2028 (K Pcs)
    Figure 13. Global Hemostats Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Hemostats Revenue 2017-2028 (US$ Million)
    Figure 15. Global Hemostats Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Hemostats Sales Market Share by Region (2017-2022)
    Figure 17. Global Hemostats Sales Market Share by Region (2023-2028)
    Figure 18. North America Hemostats Sales YoY (2017-2028) & (K Pcs)
    Figure 19. North America Hemostats Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Europe Hemostats Sales YoY (2017-2028) & (K Pcs)
    Figure 21. Europe Hemostats Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Asia-Pacific Hemostats Sales YoY (2017-2028) & (K Pcs)
    Figure 23. Asia-Pacific Hemostats Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Latin America Hemostats Sales YoY (2017-2028) & (K Pcs)
    Figure 25. Latin America Hemostats Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Middle East & Africa Hemostats Sales YoY (2017-2028) & (K Pcs)
    Figure 27. Middle East & Africa Hemostats Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. The Hemostats Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 29. The Top 5 and 10 Largest Manufacturers of Hemostats in the World: Market Share by Hemostats Revenue in 2021
    Figure 30. Global Hemostats Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 31. Global Hemostats Sales Market Share by Type (2017-2028)
    Figure 32. Global Hemostats Revenue Market Share by Type (2017-2028)
    Figure 33. Global Hemostats Sales Market Share by Application (2017-2028)
    Figure 34. Global Hemostats Revenue Market Share by Application (2017-2028)
    Figure 35. North America Hemostats Sales Market Share by Type (2017-2028)
    Figure 36. North America Hemostats Revenue Market Share by Type (2017-2028)
    Figure 37. North America Hemostats Sales Market Share by Application (2017-2028)
    Figure 38. North America Hemostats Revenue Market Share by Application (2017-2028)
    Figure 39. North America Hemostats Sales Share by Country (2017-2028)
    Figure 40. North America Hemostats Revenue Share by Country (2017-2028)
    Figure 41. U.S. Hemostats Revenue (2017-2028) & (US$ Million)
    Figure 42. Canada Hemostats Revenue (2017-2028) & (US$ Million)
    Figure 43. Europe Hemostats Sales Market Share by Type (2017-2028)
    Figure 44. Europe Hemostats Revenue Market Share by Type (2017-2028)
    Figure 45. Europe Hemostats Sales Market Share by Application (2017-2028)
    Figure 46. Europe Hemostats Revenue Market Share by Application (2017-2028)
    Figure 47. Europe Hemostats Sales Share by Country (2017-2028)
    Figure 48. Europe Hemostats Revenue Share by Country (2017-2028)
    Figure 49. Germany Hemostats Revenue (2017-2028) & (US$ Million)
    Figure 50. France Hemostats Revenue (2017-2028) & (US$ Million)
    Figure 51. U.K. Hemostats Revenue (2017-2028) & (US$ Million)
    Figure 52. Italy Hemostats Revenue (2017-2028) & (US$ Million)
    Figure 53. Russia Hemostats Revenue (2017-2028) & (US$ Million)
    Figure 54. Asia Pacific Hemostats Sales Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Hemostats Revenue Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Hemostats Sales Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Hemostats Revenue Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Hemostats Sales Share by Region (2017-2028)
    Figure 59. Asia Pacific Hemostats Revenue Share by Region (2017-2028)
    Figure 60. China Hemostats Revenue (2017-2028) & (US$ Million)
    Figure 61. Japan Hemostats Revenue (2017-2028) & (US$ Million)
    Figure 62. South Korea Hemostats Revenue (2017-2028) & (US$ Million)
    Figure 63. India Hemostats Revenue (2017-2028) & (US$ Million)
    Figure 64. Australia Hemostats Revenue (2017-2028) & (US$ Million)
    Figure 65. China Taiwan Hemostats Revenue (2017-2028) & (US$ Million)
    Figure 66. Indonesia Hemostats Revenue (2017-2028) & (US$ Million)
    Figure 67. Thailand Hemostats Revenue (2017-2028) & (US$ Million)
    Figure 68. Malaysia Hemostats Revenue (2017-2028) & (US$ Million)
    Figure 69. Latin America Hemostats Sales Market Share by Type (2017-2028)
    Figure 70. Latin America Hemostats Revenue Market Share by Type (2017-2028)
    Figure 71. Latin America Hemostats Sales Market Share by Application (2017-2028)
    Figure 72. Latin America Hemostats Revenue Market Share by Application (2017-2028)
    Figure 73. Latin America Hemostats Sales Share by Country (2017-2028)
    Figure 74. Latin America Hemostats Revenue Share by Country (2017-2028)
    Figure 75. Mexico Hemostats Revenue (2017-2028) & (US$ Million)
    Figure 76. Brazil Hemostats Revenue (2017-2028) & (US$ Million)
    Figure 77. Argentina Hemostats Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa Hemostats Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Hemostats Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Hemostats Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Hemostats Revenue Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Hemostats Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa Hemostats Revenue Share by Country (2017-2028)
    Figure 84. Turkey Hemostats Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia Hemostats Revenue (2017-2028) & (US$ Million)
    Figure 86. UAE Hemostats Revenue (2017-2028) & (US$ Million)
    Figure 87. Hemostats Value Chain
    Figure 88. Hemostats Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String